Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy
NCT ID: NCT04306107
Last Updated: 2021-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-09-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure
NCT04477655
Prone Positioning During High Flow Oxygen Therapy in Acute Hypoxemic Respiratory Failure
NCT03095300
Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NCT06966310
The Prone Position in Covid-19 Affected Patients
NCT04365959
Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure
NCT04641182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adult patients with:
• ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
Exclusion Criteria
* General NIV or HFNC contraindications
* Immediate need for IOT
* Prone position intolerance
* Patients refusal to participate
Interventions:
* Prone position for 2-4 hours twice a day, for 3 days (first 3 days since admission to ICU)
* Nurse surveilance: at least every 15 minutes
Outcomes:
* Need for IOT
* Effects on the measurements specified above (particularly PaO2/FiO2)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIV with prone position
Use of prone position during NIV
Prone position during non-invasive respiratory support
HFNC and NIV application with patient on prone position
NIV (conventional)
NIV on conventional position
Prone position during non-invasive respiratory support
HFNC and NIV application with patient on prone position
HFNC on prone position
Prone position during HFNC
Prone position during non-invasive respiratory support
HFNC and NIV application with patient on prone position
HFNC (conventional)
HFNC on conventional position
Prone position during non-invasive respiratory support
HFNC and NIV application with patient on prone position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prone position during non-invasive respiratory support
HFNC and NIV application with patient on prone position
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
Exclusion Criteria
* Immediate need for IOT
* Prone position intolerance
* Patients refusal to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Morales Meseguer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miguel Filipe Martins de Matos Navarro Guia
MD
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-03-2020 2
Identifier Type: OTHER
Identifier Source: secondary_id
10-03-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.